Skip to main content

Table 4 Evolution of blood parameters at 0, 6, 12, and 24 hours after initiation of shock treatment expressed as mean (SEM)

From: Early resuscitation of dengue shock syndrome in children with hyperosmolar sodium-lactate: a randomized single-blind clinical trial of efficacy and safety

 

Treatment

T0

T6

T12

T24

Ptreatment

Ptime

P interaction

Leukocytes, mm-3

HSL

6,217 (854)

5,600 (566)

6,665 (698)

7,100 (764)

0.862

0.001

0.844

 

RL

6,000 (755)

5,805 (842)

6,623 (816)

7,864 (1,016)

   

Thrombocytes, mm-3

HSL

47,042 (7,693)

44,583 (6,102)

40,348 (6,001)

48,773 (5,817)

0.297

0.016

0.529

 

RL

59,409 (7,421)

48,727 (5,870)

50,455 (6,583)

55,909 (4,867)

   

pH (venous)

HSL

7.40 (0.03)

7.50 (0.01)

7.50 (0.02)

7.46 (0.01)

<0.0001

<0.0001

0.100

 

RL

7.37 (0.02)

7.40 (0.01)

7.41 (0.01)

7.39 (0.01)

   

CO3H- (venous), mM

HSL

15.20 (0.87)

21.56 (1.04)

26.53 (1.19)

25.18 (0.73)

<0.0001

<0.0001

<0.0001

 

RL

13.76 (0.72)

15.21 (0.86)

16.94 (0.72)

19.35 (0.85)

   

Na, mM

HSL

129.8 (1.2)

129.8 (1.2)

130.0 (1.3)

130.6 (1.3)

0.935

0.013

0.081

 

RL

128.1 (0.9)

129.0 (1.0)

130.3 (0.8)

132.7 (1.3)

   

K, mM

HSL

4.36 (0.14)

3.42 (0.13)

3.23 (0.11)

3.18 (0.11)

<0.0001

<0.0001

0.001

 

RL

4.64 (0.17)

4.26 (0.10)

4.23 (0.16)

4.28 (0.15)

   

Cl, mM

HSL

94.3 (1.3)

90.5 (1.2)

89.5 (1.5)

92.5 (1.1)

<0.0001

0.003

<0.0001

 

RL

95.8 (1.1)

97.6 (1.0)

99.6 (1.1)

100.9 (0.9)

   

Osmolality, mOsm/Kg H2O

HSL

284.0 (4.6)

277.9 (2.2)

278.5 (2.6)

276.4 (2.2)

0.240

0.416

0.104

 

RL

275.4 (1.8)

274.2 (2.4)

275.2 (1.5)

279.5 (2.6)

   

Glucose, mM

HSL

6.74 (0.37)

6.56 (0.27)

6.60 (0.39)

5.72 (0.35)

0.003

0.001

0.355

 

RL

6.11 (0.43)

5.14 (0.27)

5.35 (0.33)

4.85 (0.29)

   

Lactate, mM

HSL

4.71 (0.67)

2.94 (0.41)

2.93 (0.32)

1.65 (0.20)

0.313

<0.0001

0.183

 

RL

3.81 (0.85)

1.87 (0.30)

2.11 (0.44)

2.24 (0.54)

   

Creatinine, mg/dl

HSL

0.677 (0.063)

0.569 (0.066)

0.631 (0.088)

0.607 (0.105)

0.070

<0.0001

0.552

 

RL

0.549 (0.039)

0.440 (0.023)

0.466 (0.030)

0.416 (0.023)

   

Albumin, g/L

HSL

32.8 (1.6)

29.5 (1.1)

28.5 (1.1)

26.5 (0.9)

0.695

<0.0001

0.287

 

RL

34.5 (1.4)

28.5 (0.8)

28.5 (0.7)

27.6 (0.9)

   

Protein, g/L

HSL

59.3 (2.4)

50.7 (2.3)

48.5 (2.6)

48.0 (1.8)

0.264

<0.0001

0.990

 

RL

62.2 (2.9)

53.1 (1.8)

51.3 (1.3)

50.2 (1.6)

   

SGOT u/L

HSL

798 (422)

870 (383)

765 (373)

503 (191)

0.636

0.776

0.263

 

RL

387 (106)

512 (229)

631 (363)

656 (355)

   

SGPT u.L-1

HSL

283 (158)

258 (103)

245 (109)

185 (76)

0.678

0.934

0.267

 

RL

118 (27)

181 (87)

218 (122)

229 (119)

   

PT, seconds

HSL

12.0 (0.7)

12.2 (0.8)

12.2 (0.6)

11.4 (0.5)

0.443

0.221

0.094

 

RL

11.5 (0.7)

11.4 (1.0)

13.6 (2.8)

17.8 (4.6)

   

aPTT, seconds

HSL

42.0 (4.5)

49.4 (4.7)

50.6 (4.8)

39.9 (2.3)

0.179

0.386

0.117

 

RL

36.6 (2.4)

39.9 (2.5)

38.3 (3.4)

44.6 (7.9)

   

Fibrinogen, mg/L

HSL

163.7 (14.6)

123.1 (10.9)

131.7 (11.1)

124.1 (7.2)

0.443

<0.0001

0.734

 

RL

154.2 (16.7)

117.6 (8.8)

110.5 (7.9)

118.4 (9.6)

   
  1. Repeated measures ANOVA between HSL and RL: P treatment, effect of treatment; P time, effect of time; P interaction, interaction between treatment and time.